Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Mitsui Chemicals Crop & Life Solutions Inc. has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 3 distinct art units, indicating some technical overlap in the subject matter currently under examination.
The company is working with 4 distinct examiners to manage these filings. Since there are 4 distinct examiners for the 4 pending office actions, each case is being handled by a different individual, which may lead to varied timelines and outcomes.
The busiest examiner for the portfolio is NOTTINGHAM, KYLE GREGORY, who is responsible for 1 pending office action. This 1 pending office action represents the standard workload for examiners assigned to this company's current applications.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOTTINGHAM, KYLE GREGORY | 1 | 61.7% | +31.9% |
| OLSEN, KAELEIGH ELIZABETH | 1 | 47.1% | +64.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18558823 | COMPOSITION WITH ENHANCED PLANT DISEASE CONTROL EFFECT AND RAINFASTNESS OF D-TAGATOSE | OLSEN, KAELEIGH ELIZABETH | 49d overdue |
| 18835946 | PYRAZOLE COMPOUND AND PEST CONTROL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT | NOTTINGHAM, KYLE GREGORY | — |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18835946 | PYRAZOLE COMPOUND AND PEST CONTROL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT | NOTTINGHAM, KYLE GREGORY | 1621 | §112 | Non-Final OA | — | Pending | Aug 05, 2024 |
| 18558823 | COMPOSITION WITH ENHANCED PLANT DISEASE CONTROL EFFECT AND RAINFASTNESS OF D-TAGATOSE | OLSEN, KAELEIGH ELIZABETH | 1619 | §103 | Final Rejection | 49d overdue | Pending | Nov 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMitsui Chemicals Crop & Life Solutions Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Kyle Gregory Nottingham has the most, with 1 of Mitsui Chemicals Crop & Life Solutions Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
